155b Commerce Drive
Hauppauge, NY 11788
United States
400 South Technology Drive,
Central Islip, NY 11722
United States
Renejix is the leading end to end CDMO accelerator for small molecule oral dosage forms at a competitive price. We have produced over 200 FDFs, 5+ billion dosages annually, and have a staff of ~500 employees. Take your molecules from concept to commercialization in record time by cutting 20 weeks off early and late phase timelines!